(SFQ) SAF Holland - Overview
Sector: Consumer Cyclical | Industry: Auto Parts | Exchange: XETRA (Germany) | Market Cap: 893m EUR | Total Return: 19.7% in 12m
Avg Turnover: 1.00M
EPS Trend: -63.9%
Rev. Trend: -71.9%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
SAF-Holland SE (SFQ) manufactures chassis-related assemblies and components for commercial vehicles. Their product range includes axle and air suspension systems, fifth wheels, coupling systems, and landing gears.
The company operates in the automotive parts and equipment sector, supplying original equipment manufacturers (OEMs). This business model typically involves long-term contracts and integration into vehicle production cycles. SFQ distributes its products globally, with operations in Europe, the Middle East, Africa, the Americas, and Asia Pacific.
Further research on ValueRay can provide detailed financials and competitive analysis.
- Commercial vehicle production volumes directly impact component demand
- Raw material price fluctuations affect manufacturing costs
- Global freight and logistics activity drives aftermarket sales
- Regulatory changes in vehicle safety and emissions create new product demand
- Currency exchange rates influence international revenue and costs
| Net Income: 58.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.91 > 1.0 |
| NWC/Revenue: 30.31% < 20% (prev 21.96%; Δ 8.35% < -1%) |
| CFO/TA 0.10 > 3% & CFO 178.1m > Net Income 58.4m |
| Net Debt (482.3m) to EBITDA (230.0m): 2.10 < 3 |
| Current Ratio: 2.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (45.2m) vs 12m ago 0.47% < -2% |
| Gross Margin: 22.00% > 18% (prev 0.23%; Δ 2.18k% > 0.5%) |
| Asset Turnover: 99.53% > 50% (prev 105.2%; Δ -5.64% > 0%) |
| Interest Coverage Ratio: 2.50 > 6 (EBITDA TTM 230.0m / Interest Expense TTM 56.6m) |
| A: 0.30 (Total Current Assets 930.5m - Total Current Liabilities 404.0m) / Total Assets 1.76b |
| B: 0.16 (Retained Earnings 283.8m / Total Assets 1.76b) |
| C: 0.08 (EBIT TTM 141.3m / Avg Total Assets 1.75b) |
| D: 0.24 (Book Value of Equity 303.6m / Total Liabilities 1.24b) |
| Altman-Z'' Score: 3.29 = A |
| DSRI: 1.21 (Receivables 255.5m/221.4m, Revenue 1.74b/1.82b) |
| GMI: 1.03 (GM 22.00% / 22.73%) |
| AQI: 0.94 (AQ_t 0.27 / AQ_t-1 0.29) |
| SGI: 0.95 (Revenue 1.74b / 1.82b) |
| TATA: -0.07 (NI 58.4m - CFO 178.1m) / TA 1.76b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
As of May 25, 2026, the stock is trading at EUR 19.10 with a total of 54,931 shares traded.
Over the past week, the price has changed by +1.07%,
over one month by +12.33%,
over three months by -0.55% and
over the past year by +19.67%.
SAF Holland has no consensus analysts rating.
P/E Trailing = 17.5714
P/E Forward = 11.8483
P/S = 0.5151
P/B = 1.7632
P/EG = 0.7375
Revenue TTM = 1.74b EUR
EBIT TTM = 141.3m EUR
EBITDA TTM = 230.0m EUR
Long Term Debt = 733.0m EUR (estimated: total debt 810.6m - short term 77.6m)
Short Term Debt = 77.6m EUR (from shortTermDebt, last quarter)
Debt = 810.6m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 482.3m EUR (from netDebt column, last quarter)
Enterprise Value = 1.36b EUR (893.4m + Debt 810.6m - CCE 339.8m)
Interest Coverage Ratio = 2.50 (Ebit TTM 141.3m / Interest Expense TTM 56.6m)
EV/FCF = 10.14x (Enterprise Value 1.36b / FCF TTM 134.5m)
FCF Yield = 9.86% (FCF TTM 134.5m / Enterprise Value 1.36b)
FCF Margin = 7.75% (FCF TTM 134.5m / Revenue TTM 1.74b)
Net Margin = 3.36% (Net Income TTM 58.4m / Revenue TTM 1.74b)
Gross Margin = 22.00% ((Revenue TTM 1.74b - Cost of Revenue TTM 1.35b) / Revenue TTM)
Gross Margin QoQ = 22.14% (prev 21.75%)
Tobins Q-Ratio = 0.78 (Enterprise Value 1.36b / Total Assets 1.76b)
Interest Expense / Debt = 1.41% (Interest Expense 11.4m / Debt 810.6m)
Taxrate = 35.31% (11.2m / 31.7m)
NOPAT = 91.4m (EBIT 141.3m * (1 - 35.31%))
Current Ratio = 2.30 (Total Current Assets 930.5m / Total Current Liabilities 404.0m)
Debt / Equity = 1.57 (Debt 810.6m / totalStockholderEquity, last quarter 516.2m)
Debt / EBITDA = 2.10 (Net Debt 482.3m / EBITDA 230.0m)
Debt / FCF = 3.59 (Net Debt 482.3m / FCF TTM 134.5m)
Total Stockholder Equity = 487.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.35% (Net Income 58.4m / Total Assets 1.76b)
RoE = 11.98% (Net Income TTM 58.4m / Total Stockholder Equity 487.5m)
RoCE = 11.58% (EBIT 141.3m / Capital Employed (Equity 487.5m + L.T.Debt 733.0m))
RoIC = 7.57% (NOPAT 91.4m / Invested Capital 1.21b)
WACC = 4.56% (E(893.4m)/V(1.70b) * Re(7.87%) + D(810.6m)/V(1.70b) * Rd(1.41%) * (1-Tc(0.35)))
Discount Rate = 7.87% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: -13.48 | Cagr: -0.06%
[DCF] Terminal Value 86.12% ; FCFF base≈146.9m ; Y1≈143.7m ; Y5≈145.9m
[DCF] Fair Price = 85.14 (EV 4.35b - Net Debt 482.3m = Equity 3.86b / Shares 45.4m; r=6.0% [WACC]; 5y FCF grow -3.16% → 3.0% )
EPS Correlation: -63.85 | EPS CAGR: -10.92% | SUE: N/A | # QB: 0
Revenue Correlation: -71.94 | Revenue CAGR: -6.14% | SUE: 0.00 | # QB: 0
EPS current Year (2026-12-31): EPS=2.09 | Chg30d=-0.06% | Revisions=+20% | GrowthEPS=+12.6% | GrowthRev=+4.3%
EPS next Year (2027-12-31): EPS=2.42 | Chg30d=+0.24% | Revisions=+20% | GrowthEPS=+15.8% | GrowthRev=+5.9%
[Analyst] Revisions Ratio: +20%